{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:23:40Z","timestamp":1716596620847},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.orcp.2024.03.009","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:08:55Z","timestamp":1712437735000},"page":"159-162","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Semaglutide as a potential treatment for\u00a0obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report"],"prefix":"10.1016","volume":"18","author":[{"given":"Jean-baptiste","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axelle Trupheme","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tournayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Marty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Avignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.orcp.2024.03.009_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000432","article-title":"Expanding the phenotype of MTOR -related disorders and the Smith-Kingsmore syndrome","volume":"6","author":"Elizondo-Plazas","year":"2020","journal-title":"Neurol Genet"},{"issue":"8","key":"10.1016\/j.orcp.2024.03.009_bib2","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41436-021-01161-6","article-title":"Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities","volume":"23","author":"Carmignac","year":"2021","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.orcp.2024.03.009_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41431-019-0418-1","article-title":"A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome","volume":"27","author":"Rodr\u00edguez-Garc\u00eda","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.orcp.2024.03.009_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/diagnostics11071269","article-title":"Brain tissue low-level mosaicism for MTOR mutation causes Smith\u2013Kingsmore phenotype with recurrent hypoglycemia\u2014a novel phenotype and a further proof for testing of an affected tissue","volume":"11","author":"Szcza\u0142uba","year":"2021","journal-title":"Diagnostics"},{"issue":"4","key":"10.1016\/j.orcp.2024.03.009_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cge.13135","article-title":"mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review","volume":"93","author":"Gordo","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.orcp.2024.03.009_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5734\/JGM.2019.16.1.27","article-title":"Smith\u2013Kingsmore syndrome: The first report of a Korean patient with the MTOR germline mutation c.5395G>A p.(Glu1799Lys)","volume":"1","author":"Lee","year":"2019","journal-title":"J Genet Med"},{"issue":"7","key":"10.1016\/j.orcp.2024.03.009_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.orcp.2024.03.009_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.orcp.2024.03.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121268","article-title":"Hypothalamic anorexigenic signaling pathways (leptin, amylin, and proopiomelanocortin) are semaglutide (GLP-1 analog) targets in obesity control in mice","volume":"313","author":"Martins","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.orcp.2024.03.009_bib10","doi-asserted-by":"crossref","unstructured":"Guan T., Xiao Y., Xie X., Meng N., Qi Q., Xu J., et al. Dulaglutide Improves Gliosis and Suppresses Apoptosis\/Autophagy Through the PI3K\/Akt\/mTOR Signaling Pathway in Vascular Dementia Rats. Neurochem Res. 1 mai 2023;48(5):1561\u20131579.","DOI":"10.1007\/s11064-022-03853-0"},{"key":"10.1016\/j.orcp.2024.03.009_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.orcp.2024.03.009_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.31982","article-title":"Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity","volume":"5","author":"Ghusn","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.orcp.2024.03.009_bib13","article-title":"Current and future state of pharmacological management of pediatric obesity","author":"Kelly","year":"2024","journal-title":"Int J Obes"},{"issue":"1","key":"10.1016\/j.orcp.2024.03.009_bib14","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1038\/s41598-017-02838-2","article-title":"GLP-1 receptor signalling promotes \u03b2-cell glucose metabolism via mTOR-dependent HIF-1\u03b1 activation","volume":"7","author":"Carlessi","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.orcp.2024.03.009_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/cells11111831","article-title":"Extracellular vesicles from adipose tissue could promote metabolic adaptation through PI3K\/Akt\/mTOR","volume":"11","author":"Delgadillo-Vel\u00e1zquez","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.orcp.2024.03.009_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fnins.2018.00756","article-title":"Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions","volume":"12","author":"Park","year":"2018","journal-title":"Front Neurosci"},{"issue":"6","key":"10.1016\/j.orcp.2024.03.009_bib17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4331\/wjbc.v12.i6.104","article-title":"Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer\u2019s disease","volume":"12","author":"Ikeda","year":"2021","journal-title":"World J Biol Chem"},{"issue":"6","key":"10.1016\/j.orcp.2024.03.009_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101922","article-title":"The mTORC1\/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice","volume":"46","author":"Reis-Barbosa","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.orcp.2024.03.009_bib19","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/en.2011-1864","article-title":"GLP-1 receptor agonists and the thyroid: c-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation","volume":"153","author":"Madsen","year":"2012","journal-title":"Endocrinology"},{"issue":"6021","key":"10.1016\/j.orcp.2024.03.009_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1 and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.orcp.2024.03.009_bib21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00125-015-3632-6","article-title":"Intestinal mTOR regulates GLP-1 production in mouse L cells","volume":"58","author":"Xu","year":"2015","journal-title":"Diabetologia"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X24000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X24000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:16:42Z","timestamp":1716531402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X24000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1871403X24000395"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2024.03.009","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide as a potential treatment for\u00a0obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2024.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of Asia Oceania Association for the Study of Obesity.","name":"copyright","label":"Copyright"}]}}